+++
title = "U.S. buys radiation sickness drug as part of long-standing program"
description = "The U.S. government this week bought $290 million in supplies of a drug designed to treat blood cell injuries following radiological and nuclear emergencies as part of what it said were long-standing efforts to prepare for potential health impacts from threats to national security."
date = "2022-10-09 20:18:33"
slug = "63432c74a87b83ae9e184712"
image = "https://i.imgur.com/GxnvrBr.jpg"
score = "1235"
categories = ['program', 'buys', 'unlimited']
+++

The U.S. government this week bought $290 million in supplies of a drug designed to treat blood cell injuries following radiological and nuclear emergencies as part of what it said were long-standing efforts to prepare for potential health impacts from threats to national security.

## Highlights

- The U.S.
- Department of Health and Human Services purchased the drug Nplate from Amgen Inc (AMGN.O) The purchase, announced Tuesday, was part of ongoing efforts to prepare for a wide range of threats including chemical, biological, radiological, nuclear, and emerging infectious diseases.
- President Joe Biden said the threat by Putin to use nuclear weapons in Ukraine has brought the world closer to "Armageddon" than at any time since the Cold-War Cuban Missile Crisis.
- The White House has said repeatedly that it has seen no indication that Russia is preparing for nuclear weapons despite what it calls Putin's "nuclear saber-rattling"

---

{{< rawhtml >}}
  <p class="article-category">
    <a target="_blank" href="https://www.reuters.com/world/us/us-buys-radiation-sickness-drug-part-long-standing-program-2022-10-07/">READ THE ORIGINAL ARTICLE</a>
  </p>
{{< /rawhtml >}}
